Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:RTRX’

Jeremy Mindich - Scopia Capital

Here’s What Hedge Funds Think About Retrophin Inc (RTRX)

Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief......(read more)
Broadfin Kevin Kotler

Retrophin Inc (RTRX) Hedge Funds Are Snapping Up

Is Retrophin Inc (NASDAQ:RTRX) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Is Retrophin Inc (RTRX) A Good Stock To Buy?

Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of......(read more)
Broadfin Kevin Kotler

Horizon Pharma PLC (HZNP), Flamel Technologies S.A. (ADR) (FLML) & More: Why Should You Consider Following Broadfin Capital’s Investment Moves?

At Insider Monkey, we think that an investor can beat the market by imitating smart moves of big hedge funds into the top pick they are bullish on. We......(read more)
biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Biotech Movers: Retrophin Inc (RTRX) and Agios Pharmaceuticals Inc (AGIO)

Summer is officially over, and the warm weather volume lull is has come to an end. It’s time for money movers to get back in front of their machines......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

What Will Retrophin Inc (RTRX) Get For Its Money On A Raptor Pharmaceutical Corp. (RPTP) Deal?

The rumor mill is working hard right now in the biotech space, and the latest word is that Retrophin Inc (NASDAQ:RTRX), the company founded by Martin......(read more)
Jeremy Mindich - Scopia Capital

Retrophin Inc. (RTRX): Scopia Capital Adds To Its Stake

Matt Sirovich and Jeremy Mindich‘s Scopia Capital  has recently filed an amended 13G with the SEC, in which reported holding 3.84 million common......(read more)
Jeremy Mindich - Scopia Capital

Retrophin, Inc. (RTRX): Hedge Funds Are Crazy About This Fallen Angel

Retrophin, Inc. (NASDAQ:RTRX) shares were trading as high as $37 last summer but like most small-cap biotech stocks lost a large chunk of its value since......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Kevin Kotler’s Healthcare Fund Broadfin Capital Just Had A Disastrous Q1

Though 2016 hasn’t been great for the overall hedge fund industry so far, it is turning out to be an especially terrible year for biotech-focused......(read more)
dna, bio, clone, helix, medical, health, research, cell, gene, microscopic, render, tech, chemistry, molecular, liquid, life, biotechnology, technology, medicine, molecule,

Top Biotech Picks of Best-Performing Hedge Fund of 2015

Bloomberg recently came out with its list of best performing hedge funds of 2015 and the fund that managed to beat all its rivals and emerge at the top......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Retrophin Inc (RTRX): Are Hedge Funds Right About This Stock?

Is Retrophin Inc (NASDAQ:RTRX) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company......(read more)
healthcare

Healthcare Fund Consonance Capital’s Top Picks For Q3 Following Monster First Half

The healthcare sector has appreciated by more than 14% so far this year, so we decided to take a look at how healthcare funds are gearing their portfolios......(read more)
Broadfin Kevin Kotler

Broadfin Capital Discloses New Stake in This Canadian Biotechnology Company

Broadfin Capital, led by Kevin Kotler, has initiated a new position in QLT Inc. (USA) (NASDAQ:QLTI). In a new filing with the U.S. Securities and Exchange......(read more)
Amicus Therapeutics

Amicus Therapeutics, Inc. (FOLD), Neurocrine Biosciences, Inc. (NBIX), and Retrophin Inc (RTRX) among Biotech Guru Joseph Edelman’s Top Healthcare Picks

Biotech Guru Joseph Edelman‘s Perceptive Advisors is known for its long-short investment approach that focuses on biotech stocks. Edelman founded......(read more)
Sergey Nivens/shutterstock.com

More Than 60% Returns For These Two Hedgies’ Favorite Health Care Picks

The health care sector has appreciated by nearly 30% over the past year. We decided to take a look at three companies that two health care-focused funds......(read more)
Steven Cohen

Recent Changes in SAC Capital Advisors’ Equity Portfolio

Steven Cohen‘s SAC Capital Advisors cut its exposure to a certain number of positions. Left with almost 16,000 shares (less than 0.10% of the......(read more)
Steve Cohen SAC CAPITAL ADVISORS

Steven Cohen Also Initiates Stake in Retrophin Inc (RTRX)

Steven Cohen, in a new filing with the SEC disclosed initiating a stake in Retrophin Inc (NASDAQ:RTRX). According to the filing, Mr. Cohen holds a total......(read more)
Broadfin Kevin Kotler

Broadfin Capital Initiates a Stake in Retrophin Inc (RTRX) Following Its Listing on NASDAQ

Kevin Kotler’s Broadfin Capital has revealed a new stake in Retrophin Inc (NASDAQ:RTRX), which amasses 6.93% of the company’s common stock, it contains......(read more)